Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis
- 15 June 2007
- journal article
- research article
- Published by Wiley in Tissue Antigens
- Vol. 70 (3), 219-227
- https://doi.org/10.1111/j.1399-0039.2007.00879.x
Abstract
Sarcoidosis is a heterogeneous disorder, both phenotypically and genetically. Two independent studies have recently shown that a functional polymorphism within butyrophilin-like 2 (BTNL2) gene predisposes to sarcoidosis independently of the human leukocyte antigen (HLA)-DRB1 alleles. However, in both studies, data analysis was not stratified by Löfgren's syndrome, a clinically and genetically distinct sarcoidosis subset. BTNL2, potentially encoding an immune coreceptor, is adjacent and in linkage disequilibrium (LD) with HLA-DRB1. We investigated six BTNL2 variants, including the functional rs2076530 (G > A), as well as HLA-DRB1 alleles, by sequence-specific primers-polymerase chain reaction, in 288 patients and 446 controls from two European countries. In the patient group as a whole, the HLA-DRB1*14 [odds ratio (OR) = 3.1, P(c) = 0.0003], DRB1*12 (OR = 2.5, P(c) = 0.003), and BTNL2 rs2076530 A allele (OR = 1.49, P(c) = 0.002) were all associated with disease susceptibility. However, after exclusion of patients presenting with Löfgren's syndrome and after adjusting for HLA-DRB1 alleles, the association between BTNL2 rs2076530 A and disease disappeared (P = 0.23). By contrast, both HLA-DRB1*14 and DRB1*12 remained strongly significant (OR = 3.60, P < 0.0001 and OR = 3.03, P = 0.003, respectively). BTNL2 haplotype 4, tagged by the rs2076530 G allele, also remained associated with non-Löfgren sarcoidosis after adjusting for HLA-DRB1 alleles (OR 0.37, P = 0.016). In summary, HLA-DRB1*14, DRB1*12, and BTNL2 haplotype 4--but not rs2076530 A--are associated with non-Löfgren sarcoidosis. However, the tight LD across the HLA complex makes it difficult to identify the precise location of the susceptibility locus/i. Larger sample sets from different ethnic groups, finer mapping, and more robust LD analyses across the HLA region are needed.Keywords
This publication has 35 references indexed in Scilit:
- Analysis of the BTNL2 truncating splice site mutation in tuberculosis, leprosy and Crohn’s diseaseTissue Antigens, 2007
- Association of the BTNL2 rs2076530 single nucleotide polymorphism with Graves’ disease appears to be secondary to DRB1 exon 2 position β74Clinical Endocrinology, 2006
- Analysis of a Functional BTNL2 Polymorphism in Type 1 Diabetes, Rheumatoid Arthritis, and Systemic Lupus ErythematosusHuman Immunology, 2005
- Association of the truncating splice site mutation in BTNL2 with multiple sclerosis is secondary to HLA-DRB1*15Human Molecular Genetics, 2005
- Genome-wide association studies: theoretical and practical concernsNature Reviews Genetics, 2005
- The B7–CD28 superfamilyNature Reviews Immunology, 2002
- Phototyping: comprehensive DNA typing for HLA‐A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence‐specific primers (PCR‐SSP)Tissue Antigens, 1995
- Analysis of restriction fragment length polymorphism for the HLA-DR gene in Japanese patients with sarcoidosis.Thorax, 1994
- High prevalence of familial sarcoidosis in an Irish population.Thorax, 1984
- The Bilateral Hilar Lymphoma Syndrome.Acta Medica Scandinavica, 1952